major insurance changes are coming to glp 1 drugs Rising Costs Lead Insurers Drop Weight Loss Drug Coverage, Further Increasing Patient Burden GLP-1 Trends: Access & Shortages,

Redox signaling mediated by the gut microbiota

This disease-associated receptor signature, combined with growing evidence that microglial polarization can be shifted toward neuroprotective (M2-like) phenotypes, has opened exciting new avenues for targeted drug discovery

For women, internal pain often means a UTI, while external pain can be from skin irritation

The lipid-soluble forms of choline enhance ex vivo responses from the gut-associated immune system in young female rat offspring

The olive branch has long been a symbol for peace and victory

Rates of new-onset alopecia were 4.24% with tirzepatide and 3.33% with semaglutide, according to a preprint submitted for peer review